Relapsed or Refractory Plasma Cell Neoplasms
3 clinical trials · Condition
◉ Watch Relapsed or Refractory Plasma Cell Neoplasms
| Record | Firm | Date |
|---|---|---|
| CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms (NCT07519187) | The General Hospital of Western Theater Command | 2026-04-23 |
| CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation (NCT06986434) | Affiliated Hospital to Academy of Military Medical Sciences | 2026-04-02 |
| CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms (NCT07077330) | Chinese PLA General Hospital | 2025-08-01 |
Track Relapsed or Refractory Plasma Cell Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.